APA (7th ed.) Citation

Ta&ieb, D., Sebag, F., Hubbard, J., Mundler, O., Henry, J., & Conte-Devolx, B. (2004). Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Clinical Endocrinology, 61(1), 102. https://doi.org/10.1111/j.1365-2265.2004.02077.x

Chicago Style (17th ed.) Citation

Ta&ieb, D., F. Sebag, J.G Hubbard, O. Mundler, J.F Henry, and B. Conte-Devolx. "Does Iodine-131 Meta-iodobenzylguanidine (MIBG) Scintigraphy Have an Impact on the Management of Sporadic and Familial Phaeochromocytoma?" Clinical Endocrinology 61, no. 1 (2004): 102. https://doi.org/10.1111/j.1365-2265.2004.02077.x.

MLA (9th ed.) Citation

Ta&ieb, D., et al. "Does Iodine-131 Meta-iodobenzylguanidine (MIBG) Scintigraphy Have an Impact on the Management of Sporadic and Familial Phaeochromocytoma?" Clinical Endocrinology, vol. 61, no. 1, 2004, p. 102, https://doi.org/10.1111/j.1365-2265.2004.02077.x.